15th October 2018
- 0 comments
Edinburgh-based venture capital firm Par Equity has invested £1.3m in a rapidly growing stem-cell research company that is helping pharmaceutical giants to develop new treatments for diseases including Parkinson’s and Alzheimer’s.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.